151 related articles for article (PubMed ID: 23979265)
21. Plasma Pentraxin 3 Differentiates Nonalcoholic Steatohepatitis (NASH) from Non-NASH.
Boga S; Koksal AR; Alkim H; Yilmaz Ozguven MB; Bayram M; Ergun M; Sisman G; Tekin Neijmann S; Alkim C
Metab Syndr Relat Disord; 2015 Nov; 13(9):393-9. PubMed ID: 26367098
[TBL] [Abstract][Full Text] [Related]
22. Relationships between plasma pentraxin 3 levels and inflammation markers patients with tunneled permanent catheter in hemodialysis.
Yigit IP; Dogukan A; Taskapan H; Comert M; Ilhan N; Ulu R; Aygen B
J Vasc Access; 2015; 16(5):377-81. PubMed ID: 26070095
[TBL] [Abstract][Full Text] [Related]
23. Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients.
Infante M; Allavena P; Garlanda C; Nebuloni M; Morenghi E; Rahal D; Roncalli M; Cavuto S; Pesce S; Monari M; Valaperta S; Montanelli A; Solomon D; Bottoni E; Errico V; Voulaz E; Bossi M; Chiesa G; Passera E; Mantovani A; Alloisio M
Int J Cancer; 2016 Feb; 138(4):983-91. PubMed ID: 26348770
[TBL] [Abstract][Full Text] [Related]
24. Serum pentraxin-3 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) predict severity of infections in acute decompensated cirrhotic patients.
Fan WC; Huang CC; Yang YY; Lin A; Lee KC; Hsieh YC; Fung CP; Hsu HC; Hou MC; Lin HC
J Microbiol Immunol Infect; 2017 Dec; 50(6):905-914. PubMed ID: 26872435
[TBL] [Abstract][Full Text] [Related]
25. Left atrial appendage morphology and silent cerebral ischemia in patients with atrial fibrillation.
Anselmino M; Scaglione M; Di Biase L; Gili S; Santangeli P; Corsinovi L; Pianelli M; Cesarani F; Faletti R; Righi D; Natale A; Gaita F
Heart Rhythm; 2014 Jan; 11(1):2-7. PubMed ID: 24120872
[TBL] [Abstract][Full Text] [Related]
26. Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia.
Baldini M; Maugeri N; Ramirez GA; Giacomassi C; Castiglioni A; Prieto-González S; Corbera-Bellalta M; Di Comite G; Papa I; Dell'antonio G; Ammirati E; Cuccovillo I; Vecchio V; Mantovani A; Rovere-Querini P; Sabbadini MG; Cid MC; Manfredi AA
Arthritis Rheum; 2012 Mar; 64(3):854-65. PubMed ID: 21989653
[TBL] [Abstract][Full Text] [Related]
27. Elevated levels of the long pentraxin 3 in paracetamol-induced human acute liver injury.
Craig DG; Lee P; Pryde EA; Walker SW; Beckett GJ; Hayes PC; Simpson KJ
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):359-67. PubMed ID: 23169308
[TBL] [Abstract][Full Text] [Related]
28. Pentraxin-3 detected in human saliva shows limited correlation with biomarkers associated with systemic inflammation.
Wetterö J; Jönsson F; von Löhneysen S; Kristenson M; Garvin P; Sjöwall C
APMIS; 2021 Jun; 129(6):304-313. PubMed ID: 33811685
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of pentraxin 3 in patients with chronic heart failure.
Kotooka N; Inoue T; Aoki S; Anan M; Komoda H; Node K
Int J Cardiol; 2008 Oct; 130(1):19-22. PubMed ID: 18045709
[TBL] [Abstract][Full Text] [Related]
30. Plasma levels of pentraxin 3 in patients with spondyloarthritis.
Nisihara R; Skare TL; Zeni JO; Rasera H; Lidani K; Messias-Reason I
Biomarkers; 2018 Feb; 23(1):14-17. PubMed ID: 28043168
[TBL] [Abstract][Full Text] [Related]
31. Pentraxin levels in non-eosinophilic versus eosinophilic asthma.
Gao P; Tang K; Wang M; Yang Q; Xu Y; Wang J; Zhao J; Xie J
Clin Exp Allergy; 2018 Aug; 48(8):981-989. PubMed ID: 29754456
[TBL] [Abstract][Full Text] [Related]
32. Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study.
Jenny NS; Arnold AM; Kuller LH; Tracy RP; Psaty BM
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):594-9. PubMed ID: 19164811
[TBL] [Abstract][Full Text] [Related]
33. [Clinical study of Pentraxin 3 in diagnosing the severity and cardiovascular function of the children with sepsis].
Kang X; Zhu Y; Zhang X
Zhonghua Er Ke Za Zhi; 2015 Aug; 53(8):592-8. PubMed ID: 26717657
[TBL] [Abstract][Full Text] [Related]
34. Pentraxin 3 as a new indicator of cardiovascular‑related death in patients with advanced chronic kidney disease.
Krzanowski M; Krzanowska K; Gajda M; Dumnicka P; Dziewierz A; Woziwodzka K; Litwin JA; Sułowicz W
Pol Arch Intern Med; 2017 Feb; 127(3):170-177. PubMed ID: 28377558
[TBL] [Abstract][Full Text] [Related]
35. Impact of anatomical features of the left atrial appendage on outcomes after cryoablation for atrial fibrillation.
Kocyigit D; Yalcin MU; Gurses KM; Turk G; Ardali S; Canpolat U; Evranos B; Yorgun H; Hazirolan T; Aytemir K
J Cardiovasc Comput Tomogr; 2019; 13(2):105-112. PubMed ID: 30639114
[TBL] [Abstract][Full Text] [Related]
36. Source of inflammatory markers in patients with atrial fibrillation.
Liuba I; Ahlmroth H; Jonasson L; Englund A; Jönsson A; Säfström K; Walfridsson H
Europace; 2008 Jul; 10(7):848-53. PubMed ID: 18523031
[TBL] [Abstract][Full Text] [Related]
37. Plasma long pentraxin 3 (PTX3) concentration is a novel marker of disease activity in patients with community-acquired pneumonia.
Kao SJ; Yang HW; Tsao SM; Cheng CW; Bien MY; Yu MC; Bai KJ; Yang SF; Chien MH
Clin Chem Lab Med; 2013 Apr; 51(4):907-13. PubMed ID: 23152412
[TBL] [Abstract][Full Text] [Related]
38. Association between the N-terminal plasma brain natriuretic peptide levels or elevated left ventricular filling pressure and thromboembolic risk in patients with non-valvular atrial fibrillation.
Yu GI; Cho KI; Kim HS; Heo JH; Cha TJ
J Cardiol; 2016 Aug; 68(2):110-6. PubMed ID: 26775889
[TBL] [Abstract][Full Text] [Related]
39. Circulating intermediate CD14++CD16+monocytes are increased in patients with atrial fibrillation and reflect the functional remodelling of the left atrium.
Suzuki A; Fukuzawa K; Yamashita T; Yoshida A; Sasaki N; Emoto T; Takei A; Fujiwara R; Nakanishi T; Yamashita S; Matsumoto A; Konishi H; Ichibori H; Hirata KI
Europace; 2017 Jan; 19(1):40-47. PubMed ID: 26826137
[TBL] [Abstract][Full Text] [Related]
40. Pentraxin-3 as a local inflammatory marker in chronic spontaneous urticaria.
Kasperska-Zajac A; Grzanka A; Misiolek M; Mazur B; Machura E
Cytokine; 2015 Dec; 76(2):566-568. PubMed ID: 25982553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
